Your SlideShare is downloading. ×
0

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Research Preview - The Global Emerging Interventional Cardiac Devices Market

481

Published on

A high degree of unmet clinical needs, the rising prevalence of ailments such as coronary artery diseases and hypertension, as well as increasing disposable incomes are creating robust opportunities …

A high degree of unmet clinical needs, the rising prevalence of ailments such as coronary artery diseases and hypertension, as well as increasing disposable incomes are creating robust opportunities for emerging interventional cardiac devices in emerging countries. Although the U.S. and European markets will witness the highest growth, device manufacturers must focus on developing economies such as India and China, where the market is growing between 12 and 15 percent per annum.

New analysis from Frost & Sullivan’s analysis on The Global Emerging Interventional Cardiac Devices Market finds the market earned revenue of $1.49 billion in 2013 and estimates this to reach $6.93 billion in 2020. The analysis covers devices for the following segments: transcatheter heart valves, renal denervation, bronchial thermoplasty, bioresorbable stents, and fractional flow reserve.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
481
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
9
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. India, China and Other Emerging Markets Key Prospects for Interventional Cardiac Device Manufactures Research PREVIEW for the The Global Emerging Interventional Cardiac Devices Market
  • 2. Sample of Key Highlights • The total revenue generated by sales of emerging interventional cardiac devices globally in 2013 was estimated to represent a X% increase over the 2012 revenue. • Revenue in the US market is projected to grow at a compound annual growth rate (CAGR) of X%, whereas revenue is projected to grow in the European market at X% and in Rest of World (ROW) at X%, indicating the highest growth. • The emerging interventional cardiac devices market is currently in its growth phase; this is attributed to increased levels of awareness of various technologies including renal denervation (RDN), fractional flow reserve (FFR), and left atrial appendage (LAA) and the availability of various products in the market. • With the availability of innovative technologies and strong clinical data evidence, the interventional cardiac devices market is expected to gain momentum in the marketplace. • The US and European markets are the highest-growing regions in the interventional cardiology space; however, the growth in these regions is likely to be offset by low procedural volumes and declining average selling prices (ASPs). Source: Frost & Sullivan analysis.
  • 3. Sample of Key Highlights • With the increase in life expectancy and an aging baby-boomer population as well as the surge in cardiac morbidities, the need for the emerging interventional cardiology market is bound to increase dramatically by 2020. • Of Brazil, Russia, India, China (BRIC), South Africa, and South Korea, India and China contribute the highest growth in terms of CAGR and are a step ahead of regions such as South Korea and Russia. • Nonetheless, the BRIC interventional cardiology device market will increase robustly over the forecast period. Outside of the BRIC nations, other highly targeted countries include Australia, Turkey, Indonesia, Malaysia, and Mexico. Source: Frost & Sullivan analysis.
  • 4. Scope and SegmentationRestraints Restraints Scope Geographic coverage Global: United States, Europe, and ROW Study period 2010–2018 Base year 2013 Forecast period 2014–2018 Monetary unit US dollars
  • 5. Scope and Segmentation Source: Frost & Sullivan analysis. • This research service analyses key data and information and provides an in-depth analysis of the global emerging interventional cardiac devices market. • The study period covered by this service for the emerging interventional cardiac devices market is from 2010 to 2020, with a CAGR period from 2013 to 2020; the base year is 2013, and the forecast period is from 2014 to 2020. • The key geographic areas covered in this study include the United States, Europe, and ROW. • The 5 key segments covered in this study include transcatheter aortic valve replacement (TAVR), renal denervation (RDN), bronchial thermoplasty (BT), bioresorbable stents, and FFR. This study does not include other emerging interventional device market segments. • This study looks at a series of emerging early-stage interventional technologies; as such, it is approved as is, and there does not need to be an aggregate total market forecast. • Revenue for emerging interventional cardiac devices manufacturing companies was obtained from companies’ annual reports and financial statements.
  • 6. Executive Summary — CEO’s Perspective Source: Frost & Sullivan analysis. 2 Significant growth of RDN is expected from various other regions, including Canada, Australia, and Latin America. 3 Favourable demographics will continue to drive the adoption of interventional cardiac devices in growing economies. 4 Technology advances will be witnessed especially in areas of bioresorbable stents and LAA. 5 A significant rise in revenue of coronary stents will be witnessed due to the growing adoption of premium-priced drug-eluting stents. 1 Drug-eluting stents may present regulatory and reimbursement challenges across different regions.
  • 7. Executive Summary — 3 Big Predictions Source: Frost & Sullivan analysis. 2 The price of the devices is increasingly becoming a major factor in competitiveness. 3 An increase in minimally invasive procedures is expected to drive the growth of the market in the next few years. 1 With the increasing use of interventional cardiac procedures, the APAC region is under tremendous pressure to increase the number of trained and skilled medical personnel.
  • 8. Details of the Full Analysis
  • 9. The Full Analysis Features the Following Content Section Slide Numbers Executive Summary 9 Market Overview 18 Competitive Playbook 26 Drivers, Restraints, and Trends 32 Forecasts and Trends 41 Market Share and Competitive Analysis 53 Transcatheter Heart Valves Segment Breakdown 55 Renal Denervation Segment Breakdown 68 Bronchial Thermoplasty Segment Breakdown 80 Bioresorbable Stents Segment Breakdown 89 Fractional Flow Reserve Segment Breakdown 99 Country Snapshot—United States 108 Country Snapshot—Europe 111
  • 10. The Full Analysis Features the Following Content Section Slide Numbers The Last Word 117 Appendix 121 Decision Support Database 125
  • 11. Key Questions the Full Analysis Answers Source: Frost & Sullivan analysis. Is the interventional cardiac devices market growing, how long will it continue to grow, and at what rate? What are the key drivers and trends that lead to growth opportunities? Which are the most promising segments for manufacturing companies to venture into? Who are the key market participants in each segment? What market predictions for the forecast period will likely affect manufacturers in the interventional cardiac devices market? Are the products and services offered today meeting customer needs, or is additional development needed? What are the trends in use and technology, and is there a shift towards any particular product segment?
  • 12. List of Exhibits Source: Frost & Sullivan research. Exhibit Slide Number Total Emerging Interventional Cardiac Devices Market: Global, 2013 15 Total Emerging Interventional Cardiac Devices Market: Market Segmentation, Global, 2013 19 Total Emerging Interventional Cardiac Devices Market: Key Market Drivers and Restraints, Global, 2014–2020 33 Total Emerging Interventional Cardiac Devices Market: Market Engineering Measurements, Global, 2013 42 Total Emerging Interventional Cardiac Devices Market: Procurement Process, Global, 2013 51 Total Interventional Cardiac Devices Market: Competitive Structure, Global, 2013 54 Transcatheter Heart Valves Segment: Market Engineering Measurements, Global, 2013 58 Transcatheter Heart Valves Segment: Revenue Forecast, Global, 2010–2020 59 Transcatheter Heart Valves Segment: Market Participants, Global, 2013 64 Transcatheter Heart Valves Segemnt: Comparison of Key TAVR Products, Global, 2013 65
  • 13. List of Exhibits Source: Frost & Sullivan research. Exhibit Slide Number Transcatheter Heart Valves Segment: Percent of Sales, Global, 2013 66 Transcatheter Heart Valves Segment: Competitive Structure, Global, 2013 67 Renal Denervation Segment: Market Engineering Measurements, Global, 2013 71 Renal Denervation Segment: Revenue Forecast, Global, 2010–2020 72 Renal Denervation Segment: Market Participants, Global, 2013 76 Renal Denervation Segment: Worldwide Market Opportunity, Global, 2013 77 Renal Devervation Segment: Percent of Sales, Global, 2013 78 Renal Denervation Segment: Competitive Structure, Global, 2013 79 Bronchial Thermoplasty Segment: Market Engineering Measurements, Global, 2013 82 Bronchial Thermoplasty Segment: Revenue Forecast, Global, 2010–2020 83
  • 14. List of Exhibits Source: Frost & Sullivan research. Exhibit Slide Number Bronchial Thermoplasty Segment: Percent of Sales, Global, 2013 87 Bronchial Thermoplasty Segment: Competitive Structure, Global, 2013 88 Bioresorbable Stents Segment: Market Engineering Measurement, Global, 2013 91 Bioresorbable Stents Segment: Revenue Forecast, Global, 2010–2020 92 Bioresorbable Stents Segment: Product Development Status, Global, 2013 96 Bioresorbable Stents Segment: Percent of Sales, Global, 2013 97 Bioresorbable Stents Segment: Competitive Structure, Global, 2013 98 Fractional Flow Reserve Segment: Market Engineering Measurement, Global, 2013 101 Fractional Flow Reserve Segment: Revenue Forecast, Global, 2010–2020 102 Fractional Flow Reserve Segment: Major Market Participants, Global, 2013 105
  • 15. List of Exhibits Source: Frost & Sullivan research. Exhibit Slide Number Fractional Flow Reserve Segment, Percent of Sales, Global, 2013 106 Fractional Flow Reserve Segment: Competitive Structure, Global, 2013 107 Decision Support Database: Prevalence of Cardiovascular Diseases , Global, 2002–2012 126 Decision Support Database: Population with Hypertension, Global, 2002–2012 127 Decision Support Database: Population Aged Above 65 Years, Global, 2007–2017 128
  • 16. Associated Multimedia Analyst Briefings Healthcare & Life Sciences http://bit.ly/1fnYtaN SlideShare Presentations Healthcare & Life Sciences http://slidesha.re/1hmrb0l Market Insight Articles Complimentary Healthcare & Life Sciences Analyst Insights http://bit.ly/1hcgeig GIL Community Frost & Sullivan Community of Growth, Innovation and Leadership http://gil-events.gilcommunity.com/ Analyst Blogs Healthcare & Life Sciences http://bit.ly/1ckACZP
  • 17. Interested in Full Access? Connect With Us Jennifer Carson North America Corporate Communications (210) 247-2450 jennifer.carson@frost.com Research Authors Swathi Allada Research Analyst Advanced Medical Technologies Venkat Rajan Principal Analyst Advanced Medical Technologies Siddharth Saha Global Research Director Advanced Medical Technologies Facebook https://www.facebook.com/FrostandSullivan LinkedIn Group https://www.linkedin.com/company/frost-&-sullivan SlideShare http://www.slideshare.net/FrostandSullivan Twitter https://twitter.com/Frost_Sullivan
  • 18. Global Perspective 40+ Offices Monitoring for Opportunities and Challenges
  • 19. Industry Convergence Comprehensive Industry Coverage Sparks Innovation Opportunities Automotive & Transportation Aerospace & Defense Measurement & Instrumentation Information & Communication Technologies HealthcareEnvironment & Building Technologies Energy & Power Systems Chemicals, Materials & Food Electronics & Security Industrial Automation & Process Control Automotive Transportation & Logistics Consumer Technologies Minerals & Mining

×